findmyKOL

Mark Applefeld, MD

Basic profile

Mercy Medical Center

ORCIDNone on fileNPI
RegionBaltimore, MD · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication1996Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Mark Applefeld is a Cardiology physician affiliated with Mercy Medical Center. OpenAlex indexes 31 publications with 1,061 citations (h-index 17).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex.

1,061citations

Total citations across indexed works.

17h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

301 Saint Paul Pl
Heart Center - Burk Bldg 310
Baltimore, MD 212022102

Telephone

410-332-9752

Registry record last updated 21 Feb 2014.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    89.4%
    Statin29.9%
    Rosuvastatin Calcium46%Atorvastatin Calcium38%Pravastatin Sodium9%Simvastatin8%
    Part D<11 patients
    Beta blocker19.8%
    Metoprolol Succinate63%Metoprolol Tartrate24%Carvedilol13%
    Part D<11 patients

    + 8 more classes in this area

  • Blood & clotting

    6.4%
    Factor Xa inhibitor4.3%
    Eliquis100%
    Part D17 patients
    P2Y12 inhibitor2.1%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    4.2%
    Potassium supplement4.2%
    Potassium Chloride100%
    Part D11 patients
Where care is delivered (Part B), 202196.5% facility · 3.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

26 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”